secwatch.observer — SEC 8-K summary
======================================

Issuer:     Outset Medical, Inc. (OM)
CIK:        0001484612
Form:       8-K
Filed at:   2025-05-14T23:59:59+00:00
Accession:  0000950170-25-070964
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Outset Medical appoints Kevin O'Boyle to board, Dale Jones resigns
------------------------------------------------------------------

- Dale E. Jones stepped down from the Board effective May 14, 2025; no disagreement with company.
- Kevin O'Boyle appointed as director and Audit Committee Chair, effective May 14, 2025.
- O'Boyle brings over 20 years healthcare leadership; former CFO of NuVasive and Advanced Biohealing.
- Patrick Hackett transitions from Audit Committee Chair; Andrea Saia moves to Compensation Committee.
- D. Keith Grossman appointed Compensation Committee Chair; committee changes effective May 14, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1484612/000095017025070964/0000950170-25-070964-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1484612/000095017025070964/om-20250510.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-070964

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer